IL6 and amyotrophic lateral sclerosis: Similarly, Lu and coauthors reported an IL-6 increase in certain subgroups of ALS patients including male patients in contrast to females, patients with spinal onset, patients with slow progression, and patients receiving riluzole treatment (Lu et al., 2016).